"Life Benefits Service, Ltd'
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lioznov, Dmitry
NCT04526990: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Checkmark Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-cont…
Recruiting
3
40000
RoW
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Placebo
CanSino Biologics Inc., Beijing Institute of Biotechnology
COVID-19
12/21
01/22
Olga, Rybina
NCT04526990: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Checkmark Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-cont…
Recruiting
3
40000
RoW
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Placebo
CanSino Biologics Inc., Beijing Institute of Biotechnology
COVID-19
12/21
01/22

Download Options